Lv6
1660 积分 2024-04-11 加入
YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial
14小时前
已完结
RNA Interference With Zilebesiran for Mild to Moderate Hypertension
5天前
已完结
Translational Population-Pharmacodynamic Modeling of a Novel Long-Acting siRNA Therapy, Inclisiran, for the Treatment of Hypercholesterolemia
6天前
已完结
Donanemab Population Pharmacokinetics, Amyloid Plaque Reduction, and Safety in Participants with Alzheimer's Disease
18天前
已完结
BMS-986397, a First-in-Class Molecular Glue Degrader of Casein Kinase 1α (CK1α) for the Treatment of Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (HR-MDS) Harboring Functional TP53
1个月前
已完结
Investigating the Influence of Covariates on Axicabtagene Ciloleucel (axi-cel) Kinetics in Patients with Non-Hodgkin’s Lymphoma
8个月前
已完结
Drug Combination Modeling: Methods and Applications in Drug Development
11个月前
已完结
Exposure‐Response Relationships in Patients With HER2‐Positive Metastatic Breast Cancer and Other Solid Tumors Treated With Trastuzumab Deruxtecan
11个月前
已完结
Physiologically Based Pharmacokinetic (PBPK) Modeling in Children
1年前
已完结
Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation During Regulatory Review
1年前
已完结
皖公网安备34019202002308
